TMO : Summary for Thermo Fisher Scientific Inc - Yahoo Finance

U.S. Markets closed

Thermo Fisher Scientific Inc. (TMO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
158.98+0.25 (+0.16%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close158.73
Bid0.00 x
Ask0.00 x
Day's Range157.58 - 158.98
52 Week Range129.13 - 160.68
Avg. Volume1,929,385
Market Cap62.8B
PE Ratio (TTM)31.23
Earnings DateN/A
Dividend & Yield0.60 (0.38%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Forbes2 days ago

    Patent Damages In The Global Supply Chain

    The Supreme Court's recent ruling in Life Technologies v. Promega is likely to bring back that staple of the global supply chain: liquidated damages clauses in contracts.

  • American City Business Journals4 days ago

    Thermo Fisher unit prevails in Supreme Court patent case

    The U.S. Supreme Court on Wednesday ruled in favor of a subsidiary of Waltham-based Thermo Fisher Scientific in a patent case with broad implications for device makers that use global supply chains. In a unanimous decision, the court ruled that a genetic testing kit made by Life Technologies, which Thermo Fisher (TMO) purchased in 2013, did not infringe patents held by Wisconsin-based Promega Corp. Life Technologies made one important component of the kit in the U.S., then sent it to a U.K. facility to be completed.

  • Reuters4 days ago

    Thermo Fisher did not infringe genetic-testing patent, U.S. top court says

    The U.S. Supreme Court on Wednesday cleared a subsidiary of biotech company Thermo Fisher Scientific Inc of infringing a genetic-testing kit patent held by Promega Corp, overturning a lower court's decision. The justices ruled 7-0 that the subsidiary, Life Technologies Corp, could not be held liable for violating the patent by shipping one part of a testing kit from the United States to Britain, where it was assembled with other components and sold overseas. California-based Life Technologies and privately held Wisconsin-based Promega both sell DNA testing kits for forensic identification, paternity testing, medical research and other uses.